Haofeng Lin
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Establishment of a human organoid-based evaluation system for assessing interspecies infection risk of animal-borne coronaviruses.
Journal: Emerging microbes & infections
Published: March 26, 2024
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1.
Journal: Signal transduction and targeted therapy
Published: December 11, 2023
The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination.
Journal: Signal transduction and targeted therapy
Published: October 13, 2022
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration.
Journal: Cell discovery
Published: September 18, 2022
A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern.
A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern.
Journal: Cellular & molecular immunology
Published: July 15, 2022
Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses.
Journal: Cell discovery
Published: November 19, 2021
Artemether, Artesunate, Arteannuin B, Echinatin, Licochalcone B and Andrographolide Effectively Inhibit SARS-CoV-2 and Related Viruses In Vitro.
Journal: Frontiers in cellular and infection microbiology
Published: March 13, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026